Condition
Myeloproliferative Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Myeloproliferative Syndrome clinical trials that are recruiting, at sites in 3 countries (most in United States (2), France (1), Belgium (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Myeloproliferative Syndrome clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Genomic profiling of blood and bone marrow samples from children and young adults with blood cancers | — | Hartford, Connecticut and 7 other locations | Recruiting | Jul 20, 2021 |
| Fecal Microbiota Transplantation to Prevent Complications After Stem Cell Transplantation | Phase 2 | Amiens and 19 other locations | Recruiting | Jun 23, 2021 |
| Comparing two conditioning regimens for allogeneic hematopoietic cell transplantation | Phase 2 | Antwerp and 9 other locations | Recruiting | Feb 25, 2019 |
| Transplantation with modified stem cells and Zoledronate for pediatric cancers | Phase 1 | Madison, Wisconsin | Recruiting | Jul 24, 2015 |
All recruiting trials (4)
-
Genomic profiling of blood and bone marrow samples from children and young adults with blood cancers
This study is testing how analyzing the genes in blood and bone marrow samples from kids and young adults with blood cancers can help doctors make better treatment decisions.
-
Fecal Microbiota Transplantation to Prevent Complications After Stem Cell Transplantation
This study is testing whether giving a special stool treatment can help prevent complications like Graft-versus-Host Disease in patients receiving stem cell transplants for blood cancers.
-
Comparing two conditioning regimens for allogeneic hematopoietic cell transplantation
This study is testing two different treatment plans for patients with blood cancers who are getting stem cell transplants from matched donors to see which one helps them stay healthy longer.
-
Transplantation with modified stem cells and Zoledronate for pediatric cancers
This study is testing a new way to use modified stem cells and a drug called Zoledronate to see if it can safely help children with tough-to-treat cancers.
Related topics
Quick answers
How many Myeloproliferative Syndrome clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), France (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.